Advanced & Experimental Research (21 Offers)
Dragon Pharma, Europe
Product Information
Dragon PharmaCompound Details
Active Substance SS-31 (Elamipretide) Lyophilized mitochondrial-targeted tetrapeptide
50 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Approximately 2–4 Hours
Detection Up to several weeks
Primary Mechanism Cardiolipin Binding / Mitochondrial Membrane Stabilisation
Mitochondrial / Cellular Energy Impact Moderate
Kalpa Pharmaceuticals LTD, India
Product Information
Kalpa PharmaceuticalsCompound Details
Active Substance MOTS-c Lyophilized mitochondrial-derived peptide (12S rRNA-c)
10 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Short-acting
Detection Up to several weeks
Primary Mechanism AMPK Activation / Mitochondrial Retrograde Signalling
Metabolic / Endurance Impact High
Peptide Hubs
Product Information
Peptide HubsCompound Details
Active Substance Epitalon (Epithalon) Lyophilized synthetic tetrapeptide (Ala-Glu-Asp-Gly)
25 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Limited human data · short-acting
Detection Limited data · Up to several weeks
Primary Mechanism Telomerase Activation / Pineal Modulation
Cellular / Regenerative Impact Moderate (limited human data)
Axiolabs
Product Information
AxiolabsCompound Details
Active Substance MOTS-c Lyophilized mitochondrial-derived peptide (12S rRNA-c)
10 mg per vial
Form Lyophilized Powder
Packaging 2 mL Vial
Estimated Half-Life Short-acting
Detection Up to several weeks
Primary Mechanism AMPK Activation / Mitochondrial Retrograde Signalling
Metabolic / Endurance Impact High
For Subcutaneous Injection
Composition: MOTS-c (Mitochondrial Peptide)
Dosage: 5 mg/vial
Unit: 2 mL Multidose Vial
Form: Lyophilized Powder
Manufactured by Peptide Hubs
